Health Results-Based Financing Impact Evaluation 2013, Health Facility Baseline Survey
Burkina Faso, 2013 - 2014
Get Microdata
Reference ID
BFA_2013_HRBFIE-FBL_v01_M
Producer(s)
Paul Jacob Robyn, Aurelia Souares, Herve Hien
Collection(s)
Metadata
Created on
Jan 13, 2017
Last modified
Jan 17, 2017
Page views
126378
Downloads
9762
F2_629_Autre, précisez (f2_629_c)
Data file: f2_aug19
Overview
Valid:
266
Invalid:
0
Type:
Discrete
Start:
658
End:
707
Width:
50
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| ACCOUCHEMENT | 1 |
0.4%
|
|
| ALAITEMENT MATERNEL | 1 |
0.4%
|
|
| ALIMENT DU JEUNE ENFANT | 1 |
0.4%
|
|
| ALIMENTATION DES ENFANTS | 1 |
0.4%
|
|
| ALIMENTATION DU JEUNE ENFA | 1 |
0.4%
|
|
| ALIMENTATION DU JEUNE ENFANT | 1 |
0.4%
|
|
| ALIMENTATION DU JEUNE ENFANT ET NOURRISSON (ANGE) | 1 |
0.4%
|
|
| ALIMENTATION DU NNE ET DU JEUNE ENFANT | 1 |
0.4%
|
|
| ALIMENTATION DU NOURRISSON ET DU JEUNE ENFANT | 1 |
0.4%
|
|
| ALIMENTATION DU NOURRISSON ET DU JEUNE ENFANT | 5 |
1.9%
|
|
| ALIMENTATION DU NOURRISSON ET DU JEUNE ENFANT ANJE | 1 |
0.4%
|
|
| ALIMENTATION DU NOURRISSON ET DU JEUNE ENFANT(ANJE | 1 |
0.4%
|
|
| ALIMENTATION DU NOURRISSON ET DU JEUNE ENFANTS | 1 |
0.4%
|
|
| ALIMENTATION DU NOUVEAU NE | 1 |
0.4%
|
|
| ALIMENTATION DU NOUVEAU NE ET JEUNE ENFANT | 1 |
0.4%
|
|
| ALLAITEMENT | 6 |
2.3%
|
|
| ALLAITEMENT EXCLUSIF | 1 |
0.4%
|
|
| ALLAITEMENT IST | 1 |
0.4%
|
|
| ALLAITEMENT M.E | 1 |
0.4%
|
|
| ALLAITEMENT MATERNEL | 8 |
3%
|
|
| ALLAITEMENT MATERNEL EXCLUSIF | 3 |
1.1%
|
|
| ALLAITEMENT MATERNELLE | 2 |
0.8%
|
|
| ALLAITEMENT(LACTATION) | 1 |
0.4%
|
|
| AMUI | 1 |
0.4%
|
|
| ANJE | 4 |
1.5%
|
|
| ANJE(ALIMENTATION DU NOURISSON ET DU JEUNE ENFANT) | 1 |
0.4%
|
|
| ASSURANCE QUALITE | 1 |
0.4%
|
|
| ATELIER NATIONAL DES ICP | 1 |
0.4%
|
|
| AUDIT DE DECES INFANTILE | 1 |
0.4%
|
|
| AUDIT DECES MATERNEL | 1 |
0.4%
|
|
| AUDIT DECES MATERNELLE | 1 |
0.4%
|
|
| AUDITS DES DECES MATERNELS | 2 |
0.8%
|
|
| AUDITS ET DECES MATERNELS | 1 |
0.4%
|
|
| AUDITS,DECES | 1 |
0.4%
|
|
| BOUILLIE ENRICHIE | 1 |
0.4%
|
|
| COMMUNICATION INTER PERSONNELLE | 1 |
0.4%
|
|
| COMMUNICATION INTERPERSONN | 2 |
0.8%
|
|
| COMMUNICATION POUR LE CHNAGEMENT DE COMPORTEMENT | 1 |
0.4%
|
|
| DBS | 1 |
0.4%
|
|
| DECES MATERNEL | 1 |
0.4%
|
|
| DECES MATERNELLE | 1 |
0.4%
|
|
| DEPISTAGE CANCER DU COL | 1 |
0.4%
|
|
| DEPISTAGE DU CANCER DU COL | 3 |
1.1%
|
|
| DIABETE | 1 |
0.4%
|
|
| DRACURCULOSE | 1 |
0.4%
|
|
| ENTRETIENT MATERIEL MEDICAUX | 1 |
0.4%
|
|
| ESQUELLES EXCISION | 1 |
0.4%
|
|
| ETUDE DE CAS ET TEMOIGNE DE MENINGITE | 1 |
0.4%
|
|
| EVIDENCE ETHUS-MEDICALE | 1 |
0.4%
|
|
| EVIDENCE MEDICALE | 1 |
0.4%
|
|
| FBR | 1 |
0.4%
|
|
| FILARIOSE LYMPHATIQUE | 5 |
1.9%
|
|
| FILARIOSE LYMPHOOTIQUE | 1 |
0.4%
|
|
| FISTULES | 1 |
0.4%
|
|
| FORMATION CONTINUE | 1 |
0.4%
|
|
| FORMATION CONTINUE DES ICP | 1 |
0.4%
|
|
| FORMATION DES FORMATEURS | 1 |
0.4%
|
|
| FORMATION DES FORMATEURS DES ASC EN SOINS ESSENTIE | 1 |
0.4%
|
|
| FORMATION DES ICP | 1 |
0.4%
|
|
| FORMATION PAM | 1 |
0.4%
|
|
| FORMATION SUR LE GDT | 1 |
0.4%
|
|
| GESTION DE LA LACTATION | 2 |
0.8%
|
|
| GESTION DES DISTRICTS | 1 |
0.4%
|
|
| GESTION LACTATION | 1 |
0.4%
|
|
| HYGIENE HOSPITALIERE | 1 |
0.4%
|
|
| HYGIENE SANITAIRE | 1 |
0.4%
|
|
| IFC | 1 |
0.4%
|
|
| INDIVIDU FAMILLE COMMUNAUTE | 1 |
0.4%
|
|
| INFECTION RESPIRATOIRE AIGUE | 4 |
1.5%
|
|
| INFECTION SEXUELLEMENT TRANSMISSIBLE IST | 1 |
0.4%
|
|
| INFECTIONS SEXUELLEMENT TRANSMISSIBLES (IST) | 1 |
0.4%
|
|
| INTRODUCTION DE NOUVEAU VACCIN | 1 |
0.4%
|
|
| INTRODUCTION DE NOUVEAUX VACCINS | 2 |
0.8%
|
|
| INTRODUCTION DES NOUVEAUX VACCINS | 5 |
1.9%
|
|
| INTRODUCTION DU NOUVEAU | 1 |
0.4%
|
|
| INTRODUCTION NOUVEAU VACCIN | 1 |
0.4%
|
|
| IRA | 3 |
1.1%
|
|
| IST | 2 |
0.8%
|
|
| IST VIH | 1 |
0.4%
|
|
| L ALLAITEMENT MATERNEL | 2 |
0.8%
|
|
| L'INTRODUCTION DES NOUVEAUX VACCINS | 1 |
0.4%
|
|
| LA LACTATION | 2 |
0.8%
|
|
| LA PEC DE COMPLICATION POST-PARTUM | 1 |
0.4%
|
|
| LA QUALITE DES SOINS | 1 |
0.4%
|
|
| LACTATION | 1 |
0.4%
|
|
| LEPRE | 2 |
0.8%
|
|
| LYMPHODERME | 1 |
0.4%
|
|
| MAMO | 1 |
0.4%
|
|
| MANAGEMENT SUPERVISION | 1 |
0.4%
|
|
| MANIFESTATIONS | 1 |
0.4%
|
|
| MATERNITE A MOINDRE RISQUE | 1 |
0.4%
|
|
| MG FEMININE | 2 |
0.8%
|
|
| MGF | 1 |
0.4%
|
|
| MOM | 1 |
0.4%
|
|
| MOMI | 2 |
0.8%
|
|
| MOMI CONSULTATION POST NATALE | 1 |
0.4%
|
|
| MOMI IRSS | 1 |
0.4%
|
|
| MONITARING | 1 |
0.4%
|
|
| MONITORAGE | 1 |
0.4%
|
|
| MONITORAGE DES ACTIVITES | 1 |
0.4%
|
|
| MONITORAT NOUVEAUX VACCINS | 1 |
0.4%
|
|
| MONITORING | 2 |
0.8%
|
|
| MONOTORING | 1 |
0.4%
|
|
| MORITORING PLAN DE PREPARATION OU ACCHEMENT ET OU | 1 |
0.4%
|
|
| MUTILATION GENITALE | 1 |
0.4%
|
|
| MUTITILATION GENITALE FEMININE | 1 |
0.4%
|
|
| MUTUEL DE SANTE | 1 |
0.4%
|
|
| NOMA | 1 |
0.4%
|
|
| NOMA INSUFFISANCE | 1 |
0.4%
|
|
| NOUVEAU VACCIN | 1 |
0.4%
|
|
| NOUVEAUX VACCINS | 1 |
0.4%
|
|
| NUTRITION | 5 |
1.9%
|
|
| OBTIMUNAGE AU NIVEAU DU CENTRE DE RECHERCHE | 1 |
0.4%
|
|
| ODONTO STAMATOLOGIE | 1 |
0.4%
|
|
| OLOTUMUNAZE AU CENTRE | 1 |
0.4%
|
|
| ORDINOGRAMME OBSTETRICALE | 1 |
0.4%
|
|
| ORIENTATION APPROCHE JEUNE PHILARIOSE LYMPHATIQUE | 1 |
0.4%
|
|
| ORPHELINAT ET ENFANTS VULNERABLES | 1 |
0.4%
|
|
| PAM | 2 |
0.8%
|
|
| PAQUET MINIMUM D'ACTIVITE | 1 |
0.4%
|
|
| PARTHOGRAMME | 2 |
0.8%
|
|
| PARTOGRAMME | 6 |
2.3%
|
|
| PCIME PEDIATRIQUE | 1 |
0.4%
|
|
| PEC DE LA FILARIOSE | 1 |
0.4%
|
|
| PEC DES URGENCES TRAUMATOLOGIQUES | 1 |
0.4%
|
|
| PEDIATRIE | 1 |
0.4%
|
|
| PHARMACIE HOSPITALIERE | 1 |
0.4%
|
|
| PHARMACO VIGILENCE | 1 |
0.4%
|
|
| PHARMACOVIGILANCE | 1 |
0.4%
|
|
| PHYLARIOSE | 2 |
0.8%
|
|
| PHYLARIOSE LYMPHATIQUE | 1 |
0.4%
|
|
| PILARIOSE LYMPHATIQUE | 1 |
0.4%
|
|
| PLAN DE PREPARATION A L'ACCOUCHEMENT | 1 |
0.4%
|
|
| PLAN DE PREPARATION A L'ACCOUCHEMENT ET URGENCES | 1 |
0.4%
|
|
| PNEUMO-ROTA | 1 |
0.4%
|
|
| POM PEDIATRIQUE | 1 |
0.4%
|
|
| POSTNATAL | 1 |
0.4%
|
|
| PREPARATION A L ACCOUCHEMENT | 2 |
0.8%
|
|
| PREPARATION A L ACCOUCHEMENT AU URGENCE OBTETRICAL | 1 |
0.4%
|
|
| PRESCRIPTION RATIONNELLE | 1 |
0.4%
|
|
| PRESENTATION DE NOUVEAU VACCIN DU PEV | 1 |
0.4%
|
|
| PRESENTATION DE NOUVEAUX VACCINS | 2 |
0.8%
|
|
| PRESTATION DES SOINS | 1 |
0.4%
|
|
| PRISE EN CHARGE CHIRURGICALES DES HYDROCELES | 1 |
0.4%
|
|
| PRISE EN CHARGE COMMUNAUTAIRE DE LA MALNUTRITION | 1 |
0.4%
|
|
| PRISE EN CHARGE DES COMPLICATION DE LA FILARIOSE | 1 |
0.4%
|
|
| PRISE EN CHARGE DES IST | 1 |
0.4%
|
|
| PRISE EN CHARGE DES MALADIES DIARRHEIQUES D'ENFANT | 1 |
0.4%
|
|
| PRISE EN CHARGE DIARRHEES | 1 |
0.4%
|
|
| PRISE EN CHARGE DU NOUVEAU NE | 1 |
0.4%
|
|
| PRISE EN CHARGES URGENCES | 1 |
0.4%
|
|
| PROGRAMME ALIMENTAIRE MONDIALE (PAM) | 1 |
0.4%
|
|
| PV VIH | 1 |
0.4%
|
|
| QUALITE DE SOINS | 1 |
0.4%
|
|
| RECHERCHE ACTION | 1 |
0.4%
|
|
| REDUCTION DE LA MORTALITE MATERNELLE | 1 |
0.4%
|
|
| REGISTRE ELECTRONIQUE | 1 |
0.4%
|
|
| REGISTRE ELECTRONIQUE DE CONSULTATION | 1 |
0.4%
|
|
| REPARATION DE MGF SOINS ESSENTIELS DU NOUVEAU NE | 1 |
0.4%
|
|
| REPARATION DE SEQUELLES D EXCISION | 1 |
0.4%
|
|
| REPARATION SEQUELLES D EXCISION | 1 |
0.4%
|
|
| SAA | 1 |
0.4%
|
|
| SANTE DES JEUNES | 1 |
0.4%
|
|
| SANTE MAERNELLE ET INFANTILE | 1 |
0.4%
|
|
| SASDE | 1 |
0.4%
|
|
| SEQUELLES D'EXCISION | 1 |
0.4%
|
|
| SOINS APRES AVORTEMENT | 1 |
0.4%
|
|
| SOINS D URGENCE DU NOUVEAU NE | 1 |
0.4%
|
|
| SOINS DU POST NAT | 1 |
0.4%
|
|
| SOINS ESSENTIEL DU NOUVEAU NE | 1 |
0.4%
|
|
| SOINS ESSENTIELS DU NOUVEAU NE | 2 |
0.8%
|
|
| SRO | 1 |
0.4%
|
|
| SRO + ZINC | 1 |
0.4%
|
|
| SRO ET ZINC DANS LE CADRE DE LA DIARRHEE INFANTILE | 1 |
0.4%
|
|
| SRO ZINC | 3 |
1.1%
|
|
| SRO ZINC,DIARRHEE | 1 |
0.4%
|
|
| SRO, ZINC | 1 |
0.4%
|
|
| SRO-ZINC | 1 |
0.4%
|
|
| SRO/ZINC | 2 |
0.8%
|
|
| STIGMATISATION ETBDISCRIMINATION SUR LES PERSONNES | 1 |
0.4%
|
|
| STRATEGIE ACCELEREE | 1 |
0.4%
|
|
| STRATEGIE AFRICAINE POUR LE DEVELOPPEMENT ENFANT | 1 |
0.4%
|
|
| SUIVI DE GROSSESSE | 1 |
0.4%
|
|
| SUIVI DU TRAVAIL D ACCOUCHEMENT | 1 |
0.4%
|
|
| SUR LA LEPRE | 1 |
0.4%
|
|
| SUR LES NOUVEAUX VACCINS | 1 |
0.4%
|
|
| SURVEILLANCE CAS PAR CAS PRISE EN CHARGE DES CAS | 1 |
0.4%
|
|
| SURVEILLANCE DE LA GROSSESSE ET ACCOUCHEMENT | 1 |
0.4%
|
|
| TRYPANOSOMIASE HUMAINE | 1 |
0.4%
|
|
| TUBERCULOSE | 1 |
0.4%
|
|
| URGENCE MEDICALE | 1 |
0.4%
|
|
| UTILISATION DU GDT | 1 |
0.4%
|
|
| VACCINATION | 1 |
0.4%
|
|
| VACCINATION ROTO, PNEUMO | 1 |
0.4%
|
|
| VERT DE GUINEE | 1 |
0.4%
|
|
| VIH PEDIATRIQUE | 5 |
1.9%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.